US Patent Number

9453226

Publication Date

9-27-2016

Abstract

A method of protecting a cell includes inhibiting an inflammasome, MyD88, IL-18, VDAC1, VDAC2, caspase-8, and/or NFκB of the cell. Administering an inhibitor of MyD88, IL-18, VDAC1, VDAC2, caspase-8, and/or NFκB can protect the cell from Alu-RNA-induced degeneration. Protecting a cell, such as an retinal pigment epithelium (RPE), can be therapeutically useful in the context of age-related macular degeneration and geographic atrophy.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

14/158,357

Filing Date

01/17/2014

Included in

Ophthalmology Commons

Share

COinS